NFKB1 and gastric cancer: Taken together, our results suggest that miR-500 overexpression activates the NF-κB signalling pathway by repressing CYLD, TAX1BP1, and OTUD7B, and consequently results in gastric cancer aggressiveness and poor clinical outcomes.